Value of contrast-enhanced ultrasonography in prostate cancer

Current Opinion in Urology

Volumn 22, Issue 4, 2012, Pages 303-309

  Kundavaram, Chandan R ^a   Halpern, Ethan J ^a   Trabulsi, Edouard J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

contrast harmonic imaging; microbubble contrast agent; prostate cancer; transrectal ultrasound; ultrasound contrast

Indexed keywords

BR 55; ECHO CONTRAST MEDIUM; SONOVUE; UNCLASSIFIED DRUG; VARDENAFIL;

CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; GRAY SCALE ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; MALE; MICROBUBBLE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; CONTRAST MEDIA; HUMANS; MALE; MICROBUBBLES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84862557769     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328354831f     Document Type: Review

References (43)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29.
2. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005; 23:8146-8151.
3. Rifkin MD, Dahnert W, Kurtz AB. State of the art: endorectal sonography of the prostate gland. AJR Am J Roentgenol 1990; 154:691-700.
4. Shinohara K, Wheeler TM, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 1989; 142:76-82.
5. Delongchamps NB, de la Roza G, Jones R, et al. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int 2009; 103:49-54.
6. Kay PA, Robb RA, Bostwick DG. Prostate cancer microvessels: A novel method for three-dimensional reconstruction and analysis. Prostate 1998; 37:270-277.
7. Louvar E, Littrup PJ, Goldstein A, et al. Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 1998; 83:135-140.
8. Lissbrant IF, Stattin P, Damber JE, Bergh A. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate 1997; 33:38-45.
9. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998; 78:940-944.
10. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: A review. Ultrasound Med Biol 1994; 20:319-333.
11. Goldberg BB, Raichlen JS, Forsberg F. Ultrasound Contrast Agents: Basic Principles and Clinical Applications. 2nd ed. London: Dunitz; 2001.
12. Sedelaar JP, Van Leenders GJ, Hulsbergen-Van de Kaa CA, et al. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 2001; 40:285-293.
13. Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res 2001; 21:2907-2913.
14. Bogers HA, Sedelaar JP, Beerlage HP, et al. Contrast-enhanced threedimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54:97-104.
15. Roy C, Buy X, Lang H, et al. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 2003; 170:69-72.
16. Frauscher F, Klauser A, Halpern EJ, et al. Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet 2001; 357:1849-1850.
17. Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002; 167:1648-1652.
18. De Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part one: simulations. Ultrasonics 1994; 32:447-453.
19. De Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part two: measurements. Ultrasonics 1994; 32:455-459.
20. Forsberg F, Goldberg BB, Liu JB, et al. On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres. J Ultrasound Med 1996; 15:853-860; quiz 861-862.
21. Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. Ultrasonic Imaging 1992; 14:134-158.
22. Schrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993; 19:567-579.
23. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms. Circulation 1995; 92:2391-2395.
24. Colon PJ, 3rd, Richards DR, Moreno CA, et al. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging. J Am Soc Echocardiogr 1997; 10:602-607.
25. Broillet A, Puginier J, Ventrone R, Schneider M. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent. Invest Radiol 1998; 33:209-215.
26. Halpern EJ, Verkh L, Forsberg F, et al. Initial experience with contrastenhanced sonography of the prostate. AJR Am J Roentgenol 2000; 174:1575-1580.
27. Linden RA, Trabulsi EJ, Forsberg F, et al. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol 2007; 178:2354-2358.
28. Trabulsi EJ, Sackett D, Gomella LG, Halpern EJ. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology 2010; 76:1025-1033.
29. Halpern EJ, Ramey JR, Strup SE, et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 2005; 104:2373-2383.
30. Wink M, Frauscher F, Cosgrove D, et al. Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 2008; 54:982-992.
31. Xie SW, Li HL, Du J, et al. Contrast-enhanced ultrasonography with contrasttuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography. BJU Int 2011. [Epub ahead of print]
32. Aigner F, Schafer G, Steiner E, et al. Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: A retrospective data analysis. World J Urol 2011. [Epub ahead of print]
33. Sano F, Terao H, Kawahara T, et al. Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer. BJU Int 2011; 107:1404-1410.
34. Seitz M, Gratzke C, Schlenker B, et al. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer. Urol Oncol 2011; 29:295-301.
35. Zhao HW, Luo JH, Xu HX, et al. The value of contrast-enhanced transrectal ultrasound in predicting the nature of prostate diseases and the Gleason score of prostate cancer by a subjective blood flow grading scale. Urol Int 2011; 87:165-170.
36. Xie SW, Li FH, Li HL, et al. Value of contrast-enhanced sonography with micro flow imaging in the diagnosis of prostate cancer. J Clin Ultrasound 2011; 39:371-377.
37. Morelli G, Pagni R, Mariani C, et al. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer. J Urol 2011; 185:2126-2131.
38. Taverna G, Morandi G, Seveso M, et al. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling. BJU Int 2011; 108: 1723-1727.
39. Halpern EJ, McCue PA, Aksnes AK, et al. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology 2002; 222:361-366.
40. Rittmaster RS, Norman RW, Thomas LN, Rowden G. Evidence for atrophy and apoptosis in the prostates of men given finasteride. J Clin Endocrinol Metab 1996; 81:814-819.
41. Ives EP,Gomella LG, Halpern EJ. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results. Radiology 2005; 237:197-201.
42. Tardy I, Pochon S, Theraulaz M, et al. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol 2010; 45:573-578.
43. Fischer T, Thomas A, Tardy I, et al. Vascular endothelial growth factor receptor 2-specific microbubbles for molecular ultrasound detection of prostate cancer in a rat model. Invest Radiol 2010; 45:675-684.